ArticleEuropean journal of medical research2024

Epigenetic modification of PHLDA2 is associated with tumor microenvironment and unfavorable outcome of immune checkpoint inhibitor-based therapies in clear cell renal cell carcinoma.

Junjie Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.